Katrin Preller

Here’s the episode you voted as our best drug episode: Magic Mushrooms! People are saying that shrooms cured their depression and anxiety. But is this for real? How could taking a trip on psychedelics fix your brain? Today, magic mushrooms ditch their tie dye for a lab coat as we go on a magical journey into the science. We talk to clinical psychologists Dr. Alan Davis and Dr. Albert Garcia-Romeu, and neuropsychologist Dr. Katrin Preller.Here’s a link to our transcript: https://bit.ly/SVFavDrugsEpThis episode does deal with depression. Here are some crisis hotlines:  United States: US National Suicide Prevention Lifeline  988 (Online chat available); US Crisis Text Line Text “GO” to 741741 Australia: Lifeline 13 11 14 (Online chat available) Canada: Canadian Association for Suicide Prevention (See link for phone numbers listed by province) United Kingdom: Samaritans 116 123 (UK and ROI) (Online chat available) Full list of international hotlines here  This episode was produced by Meryl Horn and Michelle Dang with help from Wendy Zukerman, Nick DelRose, Rose Rimler and Hannah Harris Green. We’re edited by Blythe Terrell. Fact checking by Diane Kelly. Mix and sound design of this episode was by Bobby Lord. Mix and sound design of our original episode was by Peter Leonard. Music written by Peter Leonard, Marcus Bagala, Emma Munger, and Bobby Lord. A huge thanks to all the researchers we got in touch with for this episode, including Prof. David Nichols, Dr. James Rucker, Prof. Bryan Roth, Dr. Erika Dyck, Dr. Daniel Wacker, Mary Cosimano, Dr. Fred Barrett, Dr. Natalie Gukasyan, Dr. Jeff Guss, Dr. Suresh Muthukumaraswamy. Prof. Harriet de Wit, Dr. Nadia Hutten, Dr. Vince Polito, Dr. Kim Kuypers and Dr. Matt Kasson. Thanks to all the clinical trial participants and ‘psychonauts’ who spoke to us. And special thanks to Lexi Krupp, Zukerman family and Joseph Lavelle Wilson.Science Vs is a Spotify Studios Original. Listen for free on Spotify or wherever you get your podcasts. Follow us and tap the bell for episode notifications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join the podcast as they explore the therapeutic potential of magic mushrooms for mental health, featuring personal stories, scientific research, and discussions on psychedelic experiences. Dive into the mysteries of how psychedelics affect the brain, their safety profile, and the dichotomy between magic mushrooms and science.

In this episode, David interviews psychiatrist, main researcher behind the first US Phase II trial of MDMA-assisted psychotherapy, and Senior Medical Director at MAPS Public Benefit Corporation: Dr. Michael Mithoefer; and Research Group Lead at the University of Zurich, and Principal Clinical Biomarker Lead at Boehringer Ingelheim, Katrin Preller, Ph.D. Mithoefer, Preller (and David) are speakers at the upcoming Psychedelic Medicine – Israel, which will now take place July 28 - 31, 2024, in Tel Aviv. They discuss the conference and their current research: Preller's neuroimaging and work with psilocybin for alcohol use disorder, and Mithoefer (likely) being extremely close to seeing the FDA approve MDMA-assisted psychotherapy. He talks about how the therapeutic protocols for MDMA-assisted psychotherapy were created, what it's like to be so close to legalization, and how the next challenges will be accessibility and not minimizing therapy in favor of faster turnover.  They discuss neuroplasticity and whether or not it actually translates into something in humans; the concept of performing brain scans before a psychedelic experience to look for trauma biomarkers (and how this could actually result in savings over time); the excitement of seeing clinical work and neuroscience progressing in parallel; why integration frameworks need to be individualized; and the importance of embracing different therapeutic approaches. Click here to head to the show notes page.